Also found in: Medical.
MPIF-1Myeloid Progenitor Inhibitory Factor-1
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In 1998, it initiated clinical trials for mirostipen, a recombinant Myeloid Progenitor Inhibitory Factor-1 protein (MPIF-1) for the treatment of neutropenia.
Myeloid Proliferation Inhibitory Factor (MPIF-1), also entering phase II studies, is another drug that shields bone marrow from the effects of chemotherapy drugs.
On the other hand, in the same amniotic fluid of fetuses with Down syndrome, as compared with control, we observed a significant increase in the concentration of 4 chemokines: 6Ckine, IP-10, MPIF-1, and CXCL7 (Table 3).